Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study
CONCLUSION: Primary HPV screening with HPV16/18 partial genotyping is a promising strategy to identify women at current/future risk of >CIN2 in Japan without over-referral to colposcopy.TRIAL REGISTRATION: Trial Registration: UMIN Clinical Trials Registry Identifier: UMIN000013203.PMID:34708593 | PMC:PMC8550923 | DOI:10.3802/jgo.2021.32.e86
Source: Journal of Gynecologic Oncology - Category: OBGYN Authors: Sharon J B Hanley Hiromasa Fujita Satomi Aoyama-Kikawa Mitsunori Kasamo Toshihiko Torigoe Yoshihiro Matsuno Sakuragi Noriaki COMPACT study group Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | Clinical Trials | Colposcopy | Cytology | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | Japan Health | OBGYN | Study | Women